Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial (Q35943499)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial |
scientific article |
Statements
1 reference
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial (English)
1 reference
Diabetic Retinopathy Clinical Research Network
1 reference
Adam R Glassman
1 reference
Lee M Jampol
1 reference
Neil M Bressler
1 reference
Susan B Bressler
1 reference
Roy W Beck
1 reference
John A Wells
1 reference
Allison R Ayala
1 reference
Alexander J Brucker
1 reference
Frederick L Ferris
1 reference
G Robert Hampton
1 reference
Chirag Jhaveri
1 reference
Michele Melia
1 reference
Identifiers
1 reference